Halcon Resources Corp (NYSE:HK) has shot 10.1% higher to $5.01, following sector peer Goodrich Petroleum Corporation (NYSE:GDP) into the black. HK call volume is running at 17 times the norm this afternoon, with roughly 21,000 contracts exchanged. Meanwhile, just over 1,100 HK puts have crossed the tape. Nine of the 10 most active strikes are calls, with the July 6 call accounting for nearly half of the volume. Almost all of the calls have traded on the ask side, IV has jumped 7.6 percentage points, and volume has surpassed open interest — all signs of newly bought bullish bets. However, it’s worth noting that short interest accounts for 12.5% of the stock’s total available float, and would take more than 11 sessions to buy back, at HK’s average pace of trading. As such, it’s possible that short sellers are buying the out-of-the-money calls to limit losses in the event of a continued rally. Halcon Resources Corp (NYSE:HK) shares after opening at $4.72 moved to $5.22 on last trade day and at the end of the day closed at $4.99. Company price to sales ratio in past twelve months was calculated as 2.08 and price to cash ratio as 740.82. Halcon Resources Corp (NYSE:HK) showed a positive weekly performance of 17.97%.
Dynavax Technologies Corporation (NASDAQ:DVAX) reported a loss of 9 cents per share in the fourth quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 7 cents. The loss reported in the year-ago quarter was 11 cents per share. Dynavax Technologies Corporation (NASDAQ:DVAX) shares fell -3.85% in last trading session and ended the day on $1.50. DVAX return on equity ratio is recorded as -68.30% and its return on assets is -57.90%. Dynavax Technologies Corporation (NASDAQ:DVAX) yearly performance is -31.82%.
Inovio Pharmaceuticals Inc (NYSEMKT:INO) company on announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. Inovio Pharmaceuticals Inc (NYSEMKT:INO) shares moved down -7.61% in last trading session and was closed at $2.67, while trading in range of $ 2.60 – 2.98. Inovio Pharmaceuticals Inc (NYSEMKT:INO) year to date (YTD) performance is -7.93%.
HMS Holdings Corp. (NASDAQ:HMSY) announced the appointment of Gene DeFelice as Executive Vice President General Counsel & Corporate Secretary. As a member of the executive team, Mr. DeFelice will report to William C. Lucia, President and Chief Executive Officer.HMS Holdings Corp (NASDAQ:HMSY) weekly performance is -9.09%. On last trading day company shares ended up $16.50. HMS Holdings Corp (NASDAQ:HMSY) distance from 50-day simple moving average (SMA50) is -18.30%. Analysts mean target price for the company is $26.75.